4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D4 receptors

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 9, 1999, Pages 1285-1290

  Moore, Kevin W ^a   Bonner, Katrine ^a   Jones, Elizabeth A ^a   Emms, Frances ^a   Leeson, Paul D ^a   Marwood, Rosemary ^a   Patel, Shil ^a   Patel, Smita ^a   Rowley, Michael ^a   Thomas, Steven ^a   Carling, Robert W ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYL 4 PHENYLPYRAZOLE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DOPAMINERGIC ACTIVITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHO CELLS; CLOZAPINE; CRICETINAE; HUMANS; KINETICS; PIPERIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SEROTONIN ANTAGONISTS;

EID: 0033519176     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00169-9     Document Type: Article

References (15)

1. Baldessarini, R.J.; Tarsey, D. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu.Rev. Neurosci. 1980, 3, 23.
2. Ashby, C.R.; Wang, R. Y. Pharmacological action of the atypical antipsychotic drug clozapine. Synapse, 1996, 24, 349-394.
3. (a) Seeman, P.; Guan, H. C.; Van Tol, H. M. Dopamine D4 receptors elevated in schizophrenia. Nature, 1993, 365, 441-445.
4. (b) Reynolds, G. P.; Mason, S. L. Are striatal dopamine D4 receptors increased in schizophrenia?J. Neurochem. 1994, 63, 1576-1577.
5. (c) Stefanis, N. C.; Bresnick, J. N.; Kerwin, R. W.; Schofield, W.N.; McAllister, G. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Mol. Brain Res., 1998, 53, 112-119.
6. (a) Hadley, M. S. D4 receptors and their antagonists. Med. Res. Rev., 1996, 16, 507-526.
7. (b) Kulagowski, J. J.; Patel, S. Current Pharm. Des. 1997, 3, 355-366.
8. (c) Liegeois, J. F.; Eyrolles, L.; Bruhwyler, J.; Delarge, J. Dopamine D4 receptors: A new opportunity for research on schizophrenia. Current Med. Chem. 1998, 5, 77-100.
9. Rowley, M.; Collins, I. Broughton, H. B.; Davey, W.D.; Baker, R.; Emms, F.; Marwood, R.; Patel, S.; Patel, S.; Ragan, C. I.; Freedman, S.; Leeson, P. D. 4-Heterocyclylpiperidines as selective high- Affinity ligands at the human dopamine D4 receptor. J. Med. Chem. 1996, 39, 2374-2385.
10. (equation presented)
11. Carling, R.W.; Leeson, P. D.; Moore, K. W. 5-Membered Heteroaromatic Compounds as Dopamine Antagonists. WO 9621660 (1996).
12. Freedman, S.B.; Patel, S.; Marwood, R.; Emms, F.; Seabrook, G.R.; Knowles, M.R.; McAllister, G. Expression and pharmacological characterisation of the human D3 dopamine receptor. J. Pharmacol. Exp. Ther. 1994, 286, 417-426. Marwood, R.; Emms, F.; Patel, S.; Smith, G.R.; Seabrook, G.R.; Freedman, S.B. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. J. Recep. Sig. Trans. Res. 1995, 15, 267-281.
13. Freedman, S.B.; Patel, S.; Marwood, R.; Emms, F.; Seabrook, G.R.; Knowles, M.R.; McAllister, G. Expression and pharmacological characterisation of the human D3 dopamine receptor. J. Pharmacol. Exp. Ther. 1994, 286, 417-426. Marwood, R.; Emms, F.; Patel, S.; Smith, G.R.; Seabrook, G.R.; Freedman, S.B. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. J. Recep. Sig. Trans. Res. 1995, 15, 267-281.
14. McAllister, G.; Knowles, M. R.; Wrad-Booth, S. M.; Sinclair, H. A.; Patel, S. Marwood, R.; Emms, F.; Patel, S.; Smith, G. R.; Seabrook, G. R.; Freedman, S. B. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. J. Recept. Sig. Trans. Res. 1995, 15, 267-281.
15. Carling, R.W.; Moore, K. W.; Moyes, C. R.; Jones, E. A.; Bonner, K.; Emms, F.; Marwood, R.; Patel, S.; Patel,; S.; Beer, M.; Sohal, B.; Pike, A.; And Leeson, P. D. 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydro-imidazol-2-one: A selective high affinity antagonist for the human dopamine D4 receptor with improved selectivity over ion channels. J. Med. Chem. (Submitted).